Steven St. Peter

Steven St. Peter

Founder bei Vie Venture LLC

57 Jahre
Health Technology
Finance
Consumer Services

Profil

Steven St. Peter joined the T1D Fund in November 2019.
From 2012 until 2019, Steven was Founder, President and Chief Executive Officer of Aratana Therapeutics, Inc. (NASDAQ: PETX), an animal health company focused on the licensing, development and commercialization of innovative therapeutics.
Steven was previously a Managing Director at MPM Capital in Boston where his investment scope included both venture and buyout transactions across the pharmaceutical and medical technology industries.
His investment experience also includes positions at Apax Partners and The Carlyle Group.
Over the past decades, Steven has founded, invested in and/or been involved with several life sciences companies including Align Technologies (NASDAQ: ALGN), Medpointe, ESP Pharma, SkinMedica, Omrix (NASDAQ: OMRI), Pharmathene (NYSE: PIP), Xanodyne, Syndax (NASDAQ: SNDX), EKR Therapeutics, Proteon (NASDAQ: PRTO), Rhythm (NASDAQ:RYTM) and others.
Steven has served on the Executive Committee & Board of Directors of the New England Venture Capital Association and he has been active in a variety of other professional organizations.
Previously, Steven was Assistant Clinical Professor of Medicine at Columbia University.
He received his M.D.
from Washington University and completed his residency and fellowship at the Hospital of the University of Pennsylvania.
He also holds an M.B.A.
in Finance from the Wharton School of the University of Pennsylvania and a B.A.
in Chemistry from the University of Kansas.

Aktive Positionen von Steven St. Peter

UnternehmenPositionBeginn
Kansas City Area Life Sciences Institute, Inc. Director/Board Member 01.03.2014
Founder 01.05.2012
Director/Board Member 01.11.2015
Private Equity Investor 01.11.2019
Alle aktiven Positionen von Steven St. Peter

Ehemalige bekannte Positionen von Steven St. Peter

UnternehmenPositionEnde
Chairman 01.06.2020
ARATANA THERAPEUTICS INC Founder 17.01.2019
Director/Board Member 03.10.2012
Director/Board Member -
SYNDAX PHARMACEUTICALS, INC. Director/Board Member 16.05.2012
Sehen Sie sich die Erfahrung von Steven St. Peter im Detail an

Ausbildung von Steven St. Peter

University of Washington Doctorate Degree
University of Kansas Undergraduate Degree
The Wharton School of the University of Pennsylvania Masters Business Admin

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Steven St. Peter im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

26

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen2
SYNDAX PHARMACEUTICALS, INC.

Health Technology

RHYTHM PHARMACEUTICALS, INC.

Health Technology

Private Unternehmen21

Finance

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Finance

Finance

Commercial Services

Health Technology

Miscellaneous

Health Technology

Commercial Services

Kansas City Area Life Sciences Institute, Inc.

Health Technology

Health Technology

Finance

Health Technology

Finance

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Steven St. Peter